Health Care [ 4/12 ] | Biotechnology [ 18/72 ]
NASDAQ | Common Stock
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders.
The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression.
The company was founded in 2014 and is headquartered in Baltimore, Maryland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 13, 24 | -5.14 Decreased by -12.13 K% | - |
| Mar 29, 24 | -2.94 Decreased by -2.99 K% | - |
| Nov 14, 23 | 0.06 Increased by +171.33% | - |
| Aug 14, 23 | -0.11 Decreased by -25.00% | - |
| May 15, 23 | -0.04 Increased by +99.96% | - |
| Mar 31, 23 | -0.09 Increased by +99.91% | - |
| Nov 10, 22 | -0.09 Increased by +99.91% | - |
| Aug 15, 22 | -0.09 Increased by +99.91% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | 4.04 M Increased by +210.40% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -4.17 M Decreased by -15.03% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -433.14 K Increased by +89.49% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -3.68 M Decreased by -13.68% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -3.66 M Increased by +33.02% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -3.62 M Increased by +79.97% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -4.12 M Decreased by -178.02% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by -100.00% | -3.24 M Increased by +22.29% | Decreased by N/A% Decreased by N/A% |